As the use of AI spreads through every industry and becomes more of a part of our lives every day, researchers are also ...
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
In a novel ABO-incompatible kidney transplantation, investigators converted the deceased donor kidney’s blood type.
Explore how GLP-1 receptor agonists (GLP-1RAs) are transforming diabetes and obesity care in India through innovative medical ...
The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.
At K 2025, P&G unveiled an innovation in mechanical recycling developed in collaboration with Lindner - Flexloop. The new ...
Dairy heavyweight Bel Group is exploring precision fermentation as a strategy to reshape dairy production and meet evolving ...
Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...
The immune system has a tough job: When a tiny virus invades one of our cells, that cell must detect it and, within minutes, ...
The EU is striving to maintain its artisanal roots while scaling production larger consumer bases – what are the trends ...
Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others People taking popular new ...
To truly deliver on their promise, nitrogen-fixing microbes need to up their game, says Ginkgo ag bio head, Michael Miile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results